 Your new post is loading...
Your new post is loading...
Moderna previously pledged not to enforce COVID-19-related patents but changed its stance as the pandemic shifted gears. Moderna has said it is suing rival vaccine maker Pfizer and its German partn…
Moderna’s COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech’s shot, the U.S. Centers for Disease Control and Prevention said on Tuesd…
astrazeneca, biontech, certified, corroborate, covid19, evidence, immune, infection, instruction, loss, medical, miscarriage, mixing, newborn, norwegian, pfizer, pregnancy, pregnant, protection, protocols, research, risk, vaccinated, vaccines, virus, warrants
This week Pfizer and BioNTech said that their COVID-19 vaccine was safe for children aged 5 to 11. If approved by the FDA for emergency use, it could be ready for children as early as late October.…
In the summer of 2020, as the pandemic raged, infecting more than 200,000 people a day across the globe, Pfizer CEO Albert Bourla and BioNTech CEO Uğur Şahin boarded an executive jet en route to th…
|
U.S. health advisers on Saturday recommended COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.The advisers to the Centers for Disease Control and Preventi…
Pfizer said it believes Li was offered a job at one of its competitors—Xencor Inc., a biopharmaceutical company. Pfizer claims Li is still in possession of a laptop containing documents “potentially related to numerous Pfizer vaccines, drugs, and other innovations,” with the complaint specifically...
In a new document posted ahead of a key meeting of the US Food and Drug Administration’s vaccine advisers, Pfizer says its vaccine is safe and 90.7% effective against symptomatic Covid-19 in childr…
Coronavirus: Modern vaccine generated more than double antibodies than Pfizer shot. Moderna Inc.’s Covid vaccine generated more than double the antibodies from a similar shot made by Pfizer Inc. an…
U.S health officials are expected to recommend Covid-19 vaccine booster doses for Americans across all eligible age groups eight months after they received their second vaccine dose, to ensure last…
A year ago, when the United States decided to go big on vaccines, it bet on nearly every horse, investing in a spectrum of technologies. The safest bets, in a way, repurposed the technology …
|
Scoop.it!
